CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease (Q38473823)

3 September 2017

1 reference

title

CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease (English)

1 reference

3 September 2017

author name string

Jasmin B Kuemmerle-Deschner

series ordinal

1

1 reference

3 September 2017

publication date

12 May 2015

1 reference

Seminars in Immunopathology

3 September 2017

published in

1 reference

3 September 2017

volume

37

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

377-385

1 reference

Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The infevers autoinflammatory mutation online registry: update with new genes and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

NLR, the nucleotide-binding domain leucine-rich repeat containing gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The inflammasome: a danger sensing complex triggering innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Autoinflammation: translating mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Autoinflammatory diseases: clinical and genetic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Identification of a genetically diverse sequence of porcine reproductive and respiratory syndrome virus in Slovenia and the impact on the sensitivity of four molecular tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Hearing loss in Muckle-Wells syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-015-0491-7

Obvious optic disc swelling in a patient with cryopyrin-associated periodic syndrome

21 January 2018

1 reference

12 December 2020

TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis

1 reference

12 December 2020

Recognition of infantile-onset multisystem inflammatory disease as a unique entity

1 reference

12 December 2020

Hereditary periodic fever syndromes

1 reference

12 December 2020

Diagnosis of Muckle-Wells syndrome - 33 years later.

1 reference

12 December 2020

Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood

1 reference

12 December 2020

Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)

1 reference

12 December 2020

A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants

1 reference

12 December 2020

Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation

1 reference

12 December 2020

10.1007/S00281-015-0491-7

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1032593274

0 references

Fatcat ID

release_lorteghrprcche44xxouzhufge

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lorteghrprcche44xxouzhufge

24 November 2022

mapped directly with Wikidata item

1 reference